P16INKa immunocytochemistry in fine-needle aspiration cytology smears of metastatic head and neck squamous cell carcinoma

Reni Grimes, Monica Garcia-Buitrago, Merce Jorda, Parvin Ganjei-Azar, Annapoorna Ferrell, Carmen Gomez-Fernandez

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objectives: Patients with head and neck squamous cell carcinoma (HNSCC) may initially present with neck metastases diagnosed by fine-needle aspiration (FNA). In these patients, it is critical to locate the primary site so that targeted therapy can be administered. Nearly a quarter of HNSCC are associated with human papillomavirus (HPV) infection. The great majority of HPV-related primaries originate in the oropharynx. p16INKa (p16) functions as a surrogate marker of HPV infection. We sought to determine if expression of p16 by immunocytochemistry (ICC) in neck metastases could assist in localizing the primary site to the oropharynx. Study Design: Diagnostic FNA cytology smears of neck metastases from 90 patients with biopsy-proven primary HNSCC were reviewed. Papanicolaou-stained slides were directly subjected to ICC, using p16 antibody. Results: Twenty-seven (30%) tumors expressed p16 by ICC; 74% of these p16-positive tumors were metastases from oropharynx. There was a significantly higher proportion of p16 expression in patients with primary oropharyngeal carcinoma (47%) versus those whose primary tumor was non-oropharyngeal (15%; p = 0.0013). Conclusions: p16 expression in FNA cytology smears of metastatic HNSCC is a useful indicator of oropharyngeal origin and can be used to help localize the primary site in cases where this is not clinically evident.

Original languageEnglish
Pages (from-to)33-37
Number of pages5
JournalActa Cytologica
Volume57
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Fine Needle Biopsy
Oropharynx
Cell Biology
Immunohistochemistry
Neoplasm Metastasis
Neck
Papillomavirus Infections
Neoplasms
Biomarkers
Carcinoma
Biopsy
Carcinoma, squamous cell of head and neck
Antibodies
Therapeutics

Keywords

  • Fine-needle aspiration
  • Head and neck carcinoma
  • Immunocytochemistry
  • p16INKa
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

P16INKa immunocytochemistry in fine-needle aspiration cytology smears of metastatic head and neck squamous cell carcinoma. / Grimes, Reni; Garcia-Buitrago, Monica; Jorda, Merce; Ganjei-Azar, Parvin; Ferrell, Annapoorna; Gomez-Fernandez, Carmen.

In: Acta Cytologica, Vol. 57, No. 1, 01.01.2013, p. 33-37.

Research output: Contribution to journalArticle

@article{04164abac9e14fea8e479bac6f5bf1f1,
title = "P16INKa immunocytochemistry in fine-needle aspiration cytology smears of metastatic head and neck squamous cell carcinoma",
abstract = "Objectives: Patients with head and neck squamous cell carcinoma (HNSCC) may initially present with neck metastases diagnosed by fine-needle aspiration (FNA). In these patients, it is critical to locate the primary site so that targeted therapy can be administered. Nearly a quarter of HNSCC are associated with human papillomavirus (HPV) infection. The great majority of HPV-related primaries originate in the oropharynx. p16INKa (p16) functions as a surrogate marker of HPV infection. We sought to determine if expression of p16 by immunocytochemistry (ICC) in neck metastases could assist in localizing the primary site to the oropharynx. Study Design: Diagnostic FNA cytology smears of neck metastases from 90 patients with biopsy-proven primary HNSCC were reviewed. Papanicolaou-stained slides were directly subjected to ICC, using p16 antibody. Results: Twenty-seven (30{\%}) tumors expressed p16 by ICC; 74{\%} of these p16-positive tumors were metastases from oropharynx. There was a significantly higher proportion of p16 expression in patients with primary oropharyngeal carcinoma (47{\%}) versus those whose primary tumor was non-oropharyngeal (15{\%}; p = 0.0013). Conclusions: p16 expression in FNA cytology smears of metastatic HNSCC is a useful indicator of oropharyngeal origin and can be used to help localize the primary site in cases where this is not clinically evident.",
keywords = "Fine-needle aspiration, Head and neck carcinoma, Immunocytochemistry, p16INKa, Squamous cell carcinoma",
author = "Reni Grimes and Monica Garcia-Buitrago and Merce Jorda and Parvin Ganjei-Azar and Annapoorna Ferrell and Carmen Gomez-Fernandez",
year = "2013",
month = "1",
day = "1",
doi = "10.1159/000342501",
language = "English",
volume = "57",
pages = "33--37",
journal = "Acta Cytologica",
issn = "0001-5547",
publisher = "Science Printers and Publishers Inc.",
number = "1",

}

TY - JOUR

T1 - P16INKa immunocytochemistry in fine-needle aspiration cytology smears of metastatic head and neck squamous cell carcinoma

AU - Grimes, Reni

AU - Garcia-Buitrago, Monica

AU - Jorda, Merce

AU - Ganjei-Azar, Parvin

AU - Ferrell, Annapoorna

AU - Gomez-Fernandez, Carmen

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Objectives: Patients with head and neck squamous cell carcinoma (HNSCC) may initially present with neck metastases diagnosed by fine-needle aspiration (FNA). In these patients, it is critical to locate the primary site so that targeted therapy can be administered. Nearly a quarter of HNSCC are associated with human papillomavirus (HPV) infection. The great majority of HPV-related primaries originate in the oropharynx. p16INKa (p16) functions as a surrogate marker of HPV infection. We sought to determine if expression of p16 by immunocytochemistry (ICC) in neck metastases could assist in localizing the primary site to the oropharynx. Study Design: Diagnostic FNA cytology smears of neck metastases from 90 patients with biopsy-proven primary HNSCC were reviewed. Papanicolaou-stained slides were directly subjected to ICC, using p16 antibody. Results: Twenty-seven (30%) tumors expressed p16 by ICC; 74% of these p16-positive tumors were metastases from oropharynx. There was a significantly higher proportion of p16 expression in patients with primary oropharyngeal carcinoma (47%) versus those whose primary tumor was non-oropharyngeal (15%; p = 0.0013). Conclusions: p16 expression in FNA cytology smears of metastatic HNSCC is a useful indicator of oropharyngeal origin and can be used to help localize the primary site in cases where this is not clinically evident.

AB - Objectives: Patients with head and neck squamous cell carcinoma (HNSCC) may initially present with neck metastases diagnosed by fine-needle aspiration (FNA). In these patients, it is critical to locate the primary site so that targeted therapy can be administered. Nearly a quarter of HNSCC are associated with human papillomavirus (HPV) infection. The great majority of HPV-related primaries originate in the oropharynx. p16INKa (p16) functions as a surrogate marker of HPV infection. We sought to determine if expression of p16 by immunocytochemistry (ICC) in neck metastases could assist in localizing the primary site to the oropharynx. Study Design: Diagnostic FNA cytology smears of neck metastases from 90 patients with biopsy-proven primary HNSCC were reviewed. Papanicolaou-stained slides were directly subjected to ICC, using p16 antibody. Results: Twenty-seven (30%) tumors expressed p16 by ICC; 74% of these p16-positive tumors were metastases from oropharynx. There was a significantly higher proportion of p16 expression in patients with primary oropharyngeal carcinoma (47%) versus those whose primary tumor was non-oropharyngeal (15%; p = 0.0013). Conclusions: p16 expression in FNA cytology smears of metastatic HNSCC is a useful indicator of oropharyngeal origin and can be used to help localize the primary site in cases where this is not clinically evident.

KW - Fine-needle aspiration

KW - Head and neck carcinoma

KW - Immunocytochemistry

KW - p16INKa

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84870353050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870353050&partnerID=8YFLogxK

U2 - 10.1159/000342501

DO - 10.1159/000342501

M3 - Article

C2 - 23221169

AN - SCOPUS:84870353050

VL - 57

SP - 33

EP - 37

JO - Acta Cytologica

JF - Acta Cytologica

SN - 0001-5547

IS - 1

ER -